CClinicalTrials.gg
Status unknownNCT03607136Updated Jul 31, 2018

Early Detection of Disability and Health Promotion for Community-dwelling Elderly

An interventional study of exercise training in Elderly and Sarcopenia, sponsored by Buddhist Tzu Chi General Hospital. Status unknown. Open to participants aged 50 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-07-31.

Sponsored by Buddhist Tzu Chi General Hospital · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Jul 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
50 Years to 80 Years
Sex
All
01

Study summary

This study evaluates the effects of exercise intervention on muscle strength and walking speed for the community-dwelling elderly. Half of the participants will receive exercise training, while the other half will maintain their usual activities of daily living.

Read the detailed description

Physical inactivity can result in physical frailty and sarcopenia. Physical frailty and sarcopenia are two common and mostly overlapping geriatric conditions, which may cause negative consequences of aging, such as disability, hospitalization and mortality.

Regular physical activity has been suggested to maintain or improve functional capacity and body composition, as well as delay aging process. Nevertheless, inactivity prevalence still significantly increases among older adults, especially those with a disability. One of the probable reasons is that the use of physical activities or exercise interventions is not tailored to the needs and capabilities of the elderly.

02

Conditions studied

  • Elderly
  • Sarcopenia

Browse trials for

Keywords

  • early detection
  • health promotion
  • community-dwelling
  • elderly
03

In context

Sarcopenia

1,208 studies on the registry are indexed under Sarcopenia; 402 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 775 interventional studies indexed under Sarcopenia.

Browse Sarcopenia studies →

Lead sponsor

Buddhist Tzu Chi General Hospital is the lead sponsor of 84 studies on the registry; 21 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • age greater than 50 years
  • able to follow simple instructions
  • willing to participate and sign consent form

Exclusion criteria

Exclusion Criteria:

  • unstable angina or epilepsy
  • severe visual deficits
  • cognitive dysfunction
  • other musculoskeletal conditions that will limit mobility
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    exercise training

    Participants in the exercise training group received a 12-week exercise training.

    Other: exercise training

  • No intervention
    control

    Participants in the control group did not receive any specific training programs instead of maintaining their usual activities of daily living.

Interventions

  • Otherexercise training

    Aerobic exercises, strengthening exercises, flexibility training for 60min, twice a week for 12 weeks

06

What researchers measure

Primary outcomes

  1. Walking speed

    Participants are asked to walk along a 14 m hallway. The time taken to the middle 10 m is recorded to calculate walking speed (m/s).

    Time frame: Change from baseline at 12 weeks

  2. Muscle strength

    Muscle strength is assessed using hand-hold Dynamometers

    Time frame: Change from baseline at 12 weeks

Secondary outcomes

  1. Timed up and go test

    Participants are asked to stand up, walk 3 m, turn around a cone, and return to a sitting position

    Time frame: Change from baseline at 12 weeks

  2. Walking endurance

    Participants are asked to walk back and forth along a 20-meter corridor and to cover the maximum distance possible in six minutes

    Time frame: Change from baseline at 12 weeks

  3. Sit-to-stand test

    Participants are asked to stand up and sit down 5 times.

    Time frame: Change from baseline at 12 weeks

  4. Berg balance scale

    It consists of 14 items, including sitting unsupported, standing unsupported, standing with eyes closed, standing with feet together, standing on one foot, turning to look behind, retrieving objective from floor, random standing, reaching forward with an outsrptretched arm, sit to stand, stand to sit, transfer, turning 360 degrees, stool stepping, scored from 0 to 4, "0" indicates the lowest level of function and "4" the highest level of function. Total Score = 56.

    Time frame: Change from baseline at 12 weeks

  5. Gait kinematics

    Gait kinematics are assessed by angular displacement of lower limbs using shoe-worn inertial measurement unit based device

    Time frame: Change from baseline at 12 weeks

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 31, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03607136
Lead sponsor
Buddhist Tzu Chi General Hospital
Responsible party
Sponsor
First posted
Jul 31, 2018
Start date
Aug 2018 (estimated)
Primary completion
Jul 2019 (estimated)
Completion
Jul 2020 (estimated)
Last update
Jul 31, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion